FDA to publish draft guidance for industry on significant "least burdensome" clause
This article was originally published in Clinica
Executive Summary
The US FDA will publish a draft guidance this spring implementing the FDA Modernization Act's "least burdensome" provision, according to Dr Susan Alpert, director of the agency's office of device evaluation.